Development of a drug cost calculation tool for breast cancer therapy

Hiroki Hashimoto, Michiyasu Murakami, Kyoko Shinozaki, Ryota Nakanishi, Hidetoshi Kawaguchi, Takashi Nishizaki, Shozo Senba

Research output: Contribution to journalArticle

Abstract

Drug cost is considered an important factor in treatment compliance for cancer patients. However, it is difficult to calculate individual drug costs. We were previously unable to provide sufficient information on costs to cancer patients starting drug therapy. Therefore, we developed a tool, in the form of a spreadsheet, which calculates drug costs for breast cancer treatment. This software tool runs on every terminal for electronic medical charts in our hospital. To evaluate the tool, we created 10 fictional breast cancer patient sets. Five pharmacists calculated the drug costs for a single regimen using method A (without software) and method B (with software). The pharmacists then calculated the drug costs for 3 regimens in the same way. We compared the time taken to calculate costs using method A and method B. For the single regimen, the mean time for method B (22.6+6.9 s) was 6.4-times shorter than that for method A (145.2±28.3s, p<0.0001). For the 3 regimens, the mean time for method B (35.5+5.0 s) was 8.9-times shorter than that for method A (315.8+43.1 s, p<0.0001). The differences observed were statistically significant. By using the software, we were able to shorten the calculation time for drug costs, and therefore, alleviate the burden on medical staff.

Original languageEnglish
Pages (from-to)841-845
Number of pages5
JournalJapanese Journal of Cancer and Chemotherapy
Volume42
Issue number7
Publication statusPublished - Jul 1 2015

Fingerprint

Drug Costs
Breast Neoplasms
Software
Therapeutics
Pharmacists
Medical Electronics
Costs and Cost Analysis
Medical Staff
Patient Compliance
Neoplasms
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Hashimoto, H., Murakami, M., Shinozaki, K., Nakanishi, R., Kawaguchi, H., Nishizaki, T., & Senba, S. (2015). Development of a drug cost calculation tool for breast cancer therapy. Japanese Journal of Cancer and Chemotherapy, 42(7), 841-845.

Development of a drug cost calculation tool for breast cancer therapy. / Hashimoto, Hiroki; Murakami, Michiyasu; Shinozaki, Kyoko; Nakanishi, Ryota; Kawaguchi, Hidetoshi; Nishizaki, Takashi; Senba, Shozo.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 42, No. 7, 01.07.2015, p. 841-845.

Research output: Contribution to journalArticle

Hashimoto, H, Murakami, M, Shinozaki, K, Nakanishi, R, Kawaguchi, H, Nishizaki, T & Senba, S 2015, 'Development of a drug cost calculation tool for breast cancer therapy', Japanese Journal of Cancer and Chemotherapy, vol. 42, no. 7, pp. 841-845.
Hashimoto H, Murakami M, Shinozaki K, Nakanishi R, Kawaguchi H, Nishizaki T et al. Development of a drug cost calculation tool for breast cancer therapy. Japanese Journal of Cancer and Chemotherapy. 2015 Jul 1;42(7):841-845.
Hashimoto, Hiroki ; Murakami, Michiyasu ; Shinozaki, Kyoko ; Nakanishi, Ryota ; Kawaguchi, Hidetoshi ; Nishizaki, Takashi ; Senba, Shozo. / Development of a drug cost calculation tool for breast cancer therapy. In: Japanese Journal of Cancer and Chemotherapy. 2015 ; Vol. 42, No. 7. pp. 841-845.
@article{94c4862c4dcf4cd3934ffa86073cfb54,
title = "Development of a drug cost calculation tool for breast cancer therapy",
abstract = "Drug cost is considered an important factor in treatment compliance for cancer patients. However, it is difficult to calculate individual drug costs. We were previously unable to provide sufficient information on costs to cancer patients starting drug therapy. Therefore, we developed a tool, in the form of a spreadsheet, which calculates drug costs for breast cancer treatment. This software tool runs on every terminal for electronic medical charts in our hospital. To evaluate the tool, we created 10 fictional breast cancer patient sets. Five pharmacists calculated the drug costs for a single regimen using method A (without software) and method B (with software). The pharmacists then calculated the drug costs for 3 regimens in the same way. We compared the time taken to calculate costs using method A and method B. For the single regimen, the mean time for method B (22.6+6.9 s) was 6.4-times shorter than that for method A (145.2±28.3s, p<0.0001). For the 3 regimens, the mean time for method B (35.5+5.0 s) was 8.9-times shorter than that for method A (315.8+43.1 s, p<0.0001). The differences observed were statistically significant. By using the software, we were able to shorten the calculation time for drug costs, and therefore, alleviate the burden on medical staff.",
author = "Hiroki Hashimoto and Michiyasu Murakami and Kyoko Shinozaki and Ryota Nakanishi and Hidetoshi Kawaguchi and Takashi Nishizaki and Shozo Senba",
year = "2015",
month = "7",
day = "1",
language = "English",
volume = "42",
pages = "841--845",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "7",

}

TY - JOUR

T1 - Development of a drug cost calculation tool for breast cancer therapy

AU - Hashimoto, Hiroki

AU - Murakami, Michiyasu

AU - Shinozaki, Kyoko

AU - Nakanishi, Ryota

AU - Kawaguchi, Hidetoshi

AU - Nishizaki, Takashi

AU - Senba, Shozo

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Drug cost is considered an important factor in treatment compliance for cancer patients. However, it is difficult to calculate individual drug costs. We were previously unable to provide sufficient information on costs to cancer patients starting drug therapy. Therefore, we developed a tool, in the form of a spreadsheet, which calculates drug costs for breast cancer treatment. This software tool runs on every terminal for electronic medical charts in our hospital. To evaluate the tool, we created 10 fictional breast cancer patient sets. Five pharmacists calculated the drug costs for a single regimen using method A (without software) and method B (with software). The pharmacists then calculated the drug costs for 3 regimens in the same way. We compared the time taken to calculate costs using method A and method B. For the single regimen, the mean time for method B (22.6+6.9 s) was 6.4-times shorter than that for method A (145.2±28.3s, p<0.0001). For the 3 regimens, the mean time for method B (35.5+5.0 s) was 8.9-times shorter than that for method A (315.8+43.1 s, p<0.0001). The differences observed were statistically significant. By using the software, we were able to shorten the calculation time for drug costs, and therefore, alleviate the burden on medical staff.

AB - Drug cost is considered an important factor in treatment compliance for cancer patients. However, it is difficult to calculate individual drug costs. We were previously unable to provide sufficient information on costs to cancer patients starting drug therapy. Therefore, we developed a tool, in the form of a spreadsheet, which calculates drug costs for breast cancer treatment. This software tool runs on every terminal for electronic medical charts in our hospital. To evaluate the tool, we created 10 fictional breast cancer patient sets. Five pharmacists calculated the drug costs for a single regimen using method A (without software) and method B (with software). The pharmacists then calculated the drug costs for 3 regimens in the same way. We compared the time taken to calculate costs using method A and method B. For the single regimen, the mean time for method B (22.6+6.9 s) was 6.4-times shorter than that for method A (145.2±28.3s, p<0.0001). For the 3 regimens, the mean time for method B (35.5+5.0 s) was 8.9-times shorter than that for method A (315.8+43.1 s, p<0.0001). The differences observed were statistically significant. By using the software, we were able to shorten the calculation time for drug costs, and therefore, alleviate the burden on medical staff.

UR - http://www.scopus.com/inward/record.url?scp=84942420641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942420641&partnerID=8YFLogxK

M3 - Article

C2 - 26197746

AN - SCOPUS:84942420641

VL - 42

SP - 841

EP - 845

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 7

ER -